
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Zimmer slides on Q1 results
Investors sent shares of Zimmer (NYSE:ZMH) down 5% this morning in pre-market trading after the orthopedic device maker reported sales and earnings in-line with Wall Street’s expectations, but lackluster sales of hip and knee implants.
2. Accuray’s CyberKnife goes head-to-head against Intuitive’s da Vinci robot
Accuray will go head-to-head against Intuitive Surgical in a first-of-its-kind clinical study comparing its CyberKnife radiosurgery system against the da Vinci surgical robot in efforts to establish a new gold standard for early-stage prostate cancer.
1. HeartWare wins FDA panel nod
An FDA advisory panel recommended approval for HeartWare International‘s (NSDQ:HTWR) HVAD implantable heart pump for people with end-stage heart failure, a decision that may be good news for rival heart makers Abiomed (NSDQ:ABMD) and Thoratec (NSDQ:THOR) as well.